|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/57 | |
| A61K 31/565 | |||
| A61K 47/14 | |||
| A61K 45/06 | |||
| A61K 47/10 | |||
| A61K 9/107 | |||
| A61K 9/48 |
| (11) | Patento numeris | 2861234 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13807121.2 |
| Europos patento paraiškos padavimo data | 2013-06-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/046442 |
| Data | 2013-06-18 |
| (87) | Numeris | WO 2013/192248 |
| Data | 2013-12-27 |
| (30) | Numeris | Data | Šalis |
| 201261661302 P | 2012-06-18 | US | |
| 201261662265 P | 2012-06-20 | US | |
| 201213684002 | 2012-11-21 | US | |
| PCT/US2013/0233 | 2013-01-25 | WO | |
| 201313843362 | 2013-03-15 | US |
| (72) |
CACACE, Janice Louise, US
PERSICANER, Peter H.R., US
|
| (73) |
TherapeuticsMD, Inc.,
6800 Broken Sound Parkway NW 3rd Floor, Boca Raton, FL 33487,
US
|
| (54) | PROGESTERONE FORMULATIONS |
| PROGESTERONE FORMULATIONS |